Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy
- Author
- BACHELER, L. T1 ; ANTON, E. D1 ; BECKER, M. F1 ; LASUT, A. L1 ; GEORGE, H. J1 ; SPALDING, D. R1 ; HOLLIS, G1 ; ABREMSKI, K1 ; KUDISH, P1 ; BAKER, D1 ; BUNVILLE, J1 ; KRAKOWSKI, K1 ; BOLLING, L1 ; AUJAY, M1 ; WANG, X. V1 ; ELLIS, D1
[1] DuPont Pharmaceuticals Company, Experimental Station, Wilmington, Delaware 19880-0336, United States - Source
Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 9, pp 2475-2484 ; ref : 33 ref
- CODEN
- AACHAX
- ISSN
- 0066-4804
- Scientific domain
- Microbiology, infectious diseases; Pharmacology drugs
- Publisher
- American Society for Microbiology, Washington, DC
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antiviral Association médicamenteuse Charge virale Chimiothérapie Clonage moléculaire Efavirenz Gène Homme In vitro Interaction moléculaire Isolat clinique Mutation Mécanisme action Plasma sanguin Relation dose réponse Résistance Sang Séquence nucléotide Traitement Virus HIV1 Inhibiteur reverse transcriptase Génétique Lentivirus Retroviridae Virus immunodéficience humaine Virus
- Keyword (en)
- Antiviral Drug combination Viral load Chemotherapy Molecular cloning Efavirenz Gene Human In vitro Molecular interaction Clinical isolate Mutation Mechanism of action Blood plasma Dose activity relation Resistance Blood Nucleotide sequence Treatment HIV-1 virus Reverse transcriptase inhibitor Genetics Lentivirus Retroviridae Human immunodeficiency virus Virus
- Keyword (es)
- Antiviral Asociación medicamentosa Carga vírica Quimioterapia Clonación molecular Efavirenzo Gen Hombre In vitro Interacción molecular Aislado clinico Mutación Mecanismo acción Plasma sanguíneo Relación dosis respuesta Resistencia Sangre Secuencia nucleótido Tratamiento HIV-1 virus Genética Lentivirus Retroviridae Human immunodeficiency virus Virus
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A05 Microbiology / 002A05B Bacteriology / 002A05B09 Genetics
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S05 Antiviral agents
- Discipline
- Microbiology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 1456324
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1128/AAC.44.9.2475-2484.2000 
https://dx.doi.org/10.1128/AAC.44.9.2475-2484.2000
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1128\/AAC.44.9.2475-2484.2000\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:104:\"Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Antimicrobial agents and chemotherapy\";s:9:\"\u0000*\u0000stitle\";s:28:\"Antimicrob. agents chemother\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"44\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"2475\";s:8:\"\u0000*\u0000epage\";s:4:\"2484\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0066-4804\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BACHELER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"L. T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:11:\"ANTON, E. D\";i:1;s:12:\"BECKER, M. F\";i:2;s:11:\"LASUT, A. L\";i:3;s:12:\"GEORGE, H. J\";i:4;s:14:\"SPALDING, D. R\";i:5;s:9:\"HOLLIS, G\";i:6;s:11:\"ABREMSKI, K\";i:7;s:9:\"KUDISH, P\";i:8;s:8:\"BAKER, D\";i:9;s:11:\"BUNVILLE, J\";i:10;s:12:\"KRAKOWSKI, K\";i:11;s:10:\"BOLLING, L\";i:12;s:8:\"AUJAY, M\";i:13;s:10:\"WANG, X. V\";i:14;s:8:\"ELLIS, D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AACHAX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:104:\"Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1128\/AAC.44.9.2475-2484.2000\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:104:\"Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Antimicrobial agents and chemotherapy\";s:9:\"\u0000*\u0000stitle\";s:28:\"Antimicrob. agents chemother\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"44\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"2475\";s:8:\"\u0000*\u0000epage\";s:4:\"2484\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0066-4804\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BACHELER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"L. T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:11:\"ANTON, E. D\";i:1;s:12:\"BECKER, M. F\";i:2;s:11:\"LASUT, A. L\";i:3;s:12:\"GEORGE, H. J\";i:4;s:14:\"SPALDING, D. R\";i:5;s:9:\"HOLLIS, G\";i:6;s:11:\"ABREMSKI, K\";i:7;s:9:\"KUDISH, P\";i:8;s:8:\"BAKER, D\";i:9;s:11:\"BUNVILLE, J\";i:10;s:12:\"KRAKOWSKI, K\";i:11;s:10:\"BOLLING, L\";i:12;s:8:\"AUJAY, M\";i:13;s:10:\"WANG, X. V\";i:14;s:8:\"ELLIS, D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AACHAX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:104:\"Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:31:\"10.1128\/AAC.44.9.2475-2484.2000\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1128\/AAC.44.9.2475-2484.2000\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:104:\"Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Antimicrobial agents and chemotherapy\";s:9:\"\u0000*\u0000stitle\";s:28:\"Antimicrob. agents chemother\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"44\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"2475\";s:8:\"\u0000*\u0000epage\";s:4:\"2484\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0066-4804\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BACHELER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"L. T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:11:\"ANTON, E. D\";i:1;s:12:\"BECKER, M. F\";i:2;s:11:\"LASUT, A. L\";i:3;s:12:\"GEORGE, H. J\";i:4;s:14:\"SPALDING, D. R\";i:5;s:9:\"HOLLIS, G\";i:6;s:11:\"ABREMSKI, K\";i:7;s:9:\"KUDISH, P\";i:8;s:8:\"BAKER, D\";i:9;s:11:\"BUNVILLE, J\";i:10;s:12:\"KRAKOWSKI, K\";i:11;s:10:\"BOLLING, L\";i:12;s:8:\"AUJAY, M\";i:13;s:10:\"WANG, X. V\";i:14;s:8:\"ELLIS, D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AACHAX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:104:\"Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1128\/AAC.44.9.2475-2484.2000\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:104:\"Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Antimicrobial agents and chemotherapy\";s:9:\"\u0000*\u0000stitle\";s:28:\"Antimicrob. agents chemother\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"44\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"2475\";s:8:\"\u0000*\u0000epage\";s:4:\"2484\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0066-4804\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BACHELER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"L. T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:11:\"ANTON, E. D\";i:1;s:12:\"BECKER, M. F\";i:2;s:11:\"LASUT, A. L\";i:3;s:12:\"GEORGE, H. J\";i:4;s:14:\"SPALDING, D. R\";i:5;s:9:\"HOLLIS, G\";i:6;s:11:\"ABREMSKI, K\";i:7;s:9:\"KUDISH, P\";i:8;s:8:\"BAKER, D\";i:9;s:11:\"BUNVILLE, J\";i:10;s:12:\"KRAKOWSKI, K\";i:11;s:10:\"BOLLING, L\";i:12;s:8:\"AUJAY, M\";i:13;s:10:\"WANG, X. V\";i:14;s:8:\"ELLIS, D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AACHAX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:104:\"Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1128\/AAC.44.9.2475-2484.2000\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:104:\"Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Antimicrobial agents and chemotherapy\";s:9:\"\u0000*\u0000stitle\";s:28:\"Antimicrob. agents chemother\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"44\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"2475\";s:8:\"\u0000*\u0000epage\";s:4:\"2484\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0066-4804\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BACHELER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"L. T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:11:\"ANTON, E. D\";i:1;s:12:\"BECKER, M. F\";i:2;s:11:\"LASUT, A. L\";i:3;s:12:\"GEORGE, H. J\";i:4;s:14:\"SPALDING, D. R\";i:5;s:9:\"HOLLIS, G\";i:6;s:11:\"ABREMSKI, K\";i:7;s:9:\"KUDISH, P\";i:8;s:8:\"BAKER, D\";i:9;s:11:\"BUNVILLE, J\";i:10;s:12:\"KRAKOWSKI, K\";i:11;s:10:\"BOLLING, L\";i:12;s:8:\"AUJAY, M\";i:13;s:10:\"WANG, X. V\";i:14;s:8:\"ELLIS, D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AACHAX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:104:\"Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
